A comprehensive view of BlueRock Therapeutics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
FUJIFILM Cellular Dynamics and Opsis Therapeutics announce license with BlueRock Therapeutics for iPSC-derived cell therapy candidate
Published:
January 23, 2024
by Fujifilm Corp.
|
Ask us about our Health Care Sector market view